MedPath

Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study

Phase 2
Withdrawn
Conditions
Seizure, Alcohol Related
Interventions
Registration Number
NCT00627133
Lead Sponsor
Medical University of South Carolina
Brief Summary

Pilot study to evaluate efficacy of Keppra (levetiracetam) for seizure control in patients with alcohol related seizures.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • No trauma
  • Not pregnant
  • No other cause for seizure (hypoglycemia, CNS causes, trauma)
  • Good family support
  • Working telephone contact
Exclusion Criteria
  • Pregnancy
  • Renal failure (creatine > 2mg/dl
  • Fever or illness
  • Hypotension
  • Any trauma

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1levetiracetam-
Primary Outcome Measures
NameTimeMethod
Decreased seizures1, 2, 4, 8 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath